Notes
DA-EPOCH-R (Etoposide + Prednisone + Vincristine + Cyclophosphamide + Doxorubicin + Rituximab)
Hyper CVAD [Cyclophosphamide, Vincristine, Doxorubicin (which is also called Adriamycin), Dexamethasone (steroid) + Methotrexate and Cytarabine
References
Kiresi DA, Kivrak AS, Ecirli S, Toy H. Secondary breast, pancreatic, and renal involvement with non-Hodgkin's lymphoma: imaging findings. Breast (Edinburgh, Scotland). 2006;15(1):106–10.
Blouhos K, Boulas KA, Paraskeva A, Kariotis I, Barettas N, Hatzigeorgiadis A. Obstructive jaundice as primary presentation of a stage IIE non-Hodgkin lymphoma: a decision making process between advanced lymphoma and locally advanced/metastatic pancreatic adenocarcinoma. Int J Surg Case Rep. 2018;44:226–9.
Saif MW, Khubchandani S, Walczak M. Secondary pancreatic involvement by a diffuse large B-cell lymphoma presenting as acute pancreatitis. World J Gastroenterol. 2007;13(36):4909–11.
Bernardeau M, Auroux J, Cavicchi M, Haioun C, Tsakiris L, Delchier JC. Secondary pancreatic involvement by diffuse large B-cell lymphoma presenting as acute pancreatitis: treatment and outcome. Pancreatology. 2002;2(4):427–30.
Balagoni H, Bhogal SS, Koppurapu V, Young M. A rare case of systemic diffuse B-cell lymphoma presenting as pancreatitis. Pancreatology. 2017;17(4, Supplement):S27.
Van Beers B, Lalonde L, Soyer P, Grandin C, Trigaux JP, De Ronde T, et al. Dynamic CT in pancreatic lymphoma. J Comput Assist Tomogr. 1993;17(1):94–7.
Anand D, Lall C, Bhosale P, Ganeshan D, Qayyum A. Current update on primary pancreatic lymphoma. Abdom Radiol (New York). 2016;41(2):347–55.
Merkle EM, Bender GN, Brambs HJ. Imaging findings in pancreatic lymphoma: differential aspects. AJR Am J Roentgenol. 2000;174(3):671–5.
Dong A, Cui Y, Gao L, Wang Y, Zuo C, Yang J. Patterns of FDG uptake in pancreatic non-Hodgkin's lymphoma lesions. Abdom Imaging. 2014;39(1):175–86.
Johnson EA, Benson ME, Guda N, Pfau PR, Frick TJ, Gopal DV. Differentiating primary pancreatic lymphoma from adenocarcinoma using endoscopic ultrasound characteristics and flow cytometry: a case-control study. Endoscopic Ultrasound. 2014;3(4):221–5.
Krishna NB, LaBundy JL, Saripalli S, Safdar R, Agarwal B. Diagnostic value of EUS-FNA in patients suspected of having pancreatic cancer with a focal lesion on CT scan/MRI but without obstructive jaundice. Pancreas. 2009;38(6):625–30.
Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2015;26(suppl_5):v116–v25.
Acknowledgements
Sandra J. Admire BS MT (ASCP), Lead Clinical Laboratory Scientist, OUMC Flow Cytometry Laboratory.
Author information
Authors and Affiliations
Contributions
Maham Hayat M.D., case report drafting and discussion writing; Taseen A. Syed M.D., case report writing, literature review, and discussion writing; Molly Disbrow M.D., case report writing and finalizing the manuscript; Ngoc Thy Bao Tran M.D., image selection; Zain Asad M.D., literature review; William M. Tierney M.D., critical revision of the article and final approval of the manuscript. All authors reviewed the final manuscript before submission.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Informed Consent
Informed patient consent was obtained for case publication.
Article Guarantor
William M. Tierney M.D.
Rights and permissions
About this article
Cite this article
Hayat, M., Syed, T.A., Disbrow, M. et al. Recurrent Pancreatitis Secondary to Diffuse Large B Cell Lymphoma. J Gastrointest Canc 50, 1009–1013 (2019). https://doi.org/10.1007/s12029-018-0175-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-018-0175-3